Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy: Recommendations From the I-SPY Pathology Working Group

Authors: Sahoo, Sunati, Krings, Gregor, Chen, Yunn-Yi, Carter, Jodi M., Chen, Beiyun, Guo, Hua, Hibshoosh, Hanina, Reisenbichler, Emily, Fan, Fang, Wei, Shi

Source: Archives of pathology & laboratory medicine. 147(5):591-603

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632111720&indx=1&recIds=ETOCRN632111720

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

Authors: Robbins, Charles J., Fernandez, Aileen I., Han, Gang, Wong, Serena, Harigopal, Malini, Podoll, Mirna, Singh, Kamaljeet, Ly, Amy, Kuba, M. Gabriela, Wen, Hannah, Sanders, Mary Ann, Brock, Jane, Wei, Shi, Fadare, Oluwole, Hanley, Krisztina, Jorns, Julie, Snir, Olivia L., Yoon, Esther, Rabe, Kim, Soong, T. Rinda, Reisenbichler, Emily S., Rimm, David L.

Source: In Modern Pathology January 2023 36(1)

Determination of the number of observers needed to evaluate a subjective test and its application in two PD‐L1 studies

Authors: Han, Gang, Schell, Michael J., Reisenbichler, Emily S., Guo, Bohong, Rimm, David L.

Source: Statistics in medicine. 41(8):1361-1375

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100144678355.0x000001&indx=1&recIds=ETOCvdc_100144678355.0x000001

Rare germline variants in cancer-relevant genes are associated with breast cancer risk in young women with high-risk family history.

Authors: Rozenblit, Mariya, Qing, Tao, Ye, Yixuan, Zhao, Hongyu, Hofstatter, Erin, Singh, Vinit, Reisenbichler, Emily, Murray, Michael, Pusztai, Lajos

Source: Breast Cancer Research & Treatment; Jan2025, Vol. 209 Issue 1, p21-26, 6p

Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer

Authors: Farahmand, Saman, Fernandez, Aileen I., Ahmed, Fahad Shabbir, Rimm, David L., Chuang, Jeffrey H., Reisenbichler, Emily, Zarringhalam, Kourosh

Source: In Modern Pathology January 2022 35(1):44-51

Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study

Authors: Van Bockstal, Mieke R., François, Aline, Altinay, Serdar, Arnould, Laurent, Balkenhol, Maschenka, Broeckx, Glenn, Burguès, Octavio, Colpaert, Cecile, Dedeurwaerdere, Franceska, Dessauvagie, Benjamin, Duwel, Valérie, Floris, Giuseppe, Fox, Stephen, Gerosa, Clara, Hastir, Delfyne, Jaffer, Shabnam, Kurpershoek, Eline, Lacroix-Triki, Magali, Laka, Andoni, Lambein, Kathleen, MacGrogan, Gaëtan Marie, Marchiò, Caterina, Martin Martinez, Maria-Dolores, Nofech-Mozes, Sharon, Peeters, Dieter, Ravarino, Alberto, Reisenbichler, Emily, Resetkova, Erika, Sanati, Souzan, Schelfhout, Anne-Marie, Schelfhout, Vera, Shaaban, Abeer, Sinke, Renata, Stanciu-Pop, Claudia M., van Deurzen, Carolien H.M., Van de Vijver, Koen K., Van Rompuy, Anne-Sophie, Vincent-Salomon, Anne, Wen, Hannah Y., Wong, Serena, Bouzin, Caroline, Galant, Christine

Source: In Modern Pathology December 2021 34(12):2130-2140

Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions

Authors: Chen, Po-Han, Bossuyt, Veerle, Reisenbichler, Emily

Source: In Human Pathology February 2021 108:68-75

LMNA‐NTRK1 rearranged mesenchymal tumor (lipofibromatosis‐like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans

Authors: Panse, Gauri, Reisenbichler, Emily, Snuderl, Matija, Wang, Wei‐Lien, Laskin, William, Jour, George

Source: Journal of cutaneous pathology. 48(2):290-294

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100113511646.0x000001&indx=1&recIds=ETOCvdc_100113511646.0x000001

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

Authors: Reisenbichler, Emily S., Han, Gang, Bellizzi, Andrew, Bossuyt, Veerle, Brock, Jane, Cole, Kimberly, Fadare, Oluwole, Hameed, Omar, Hanley, Krisztina, Harrison, Beth T., Kuba, M. Gabriela, Ly, Amy, Miller, Dylan, Podoll, Mirna, Roden, Anja C., Singh, Kamaljeet, Sanders, Mary Ann, Wei, Shi, Wen, Hannah, Pelekanou, Vasiliki, Yaghoobi, Vesal, Ahmed, Fahad, Pusztai, Lajos, Rimm, David L.

Source: In Modern Pathology September 2020 33(9):1746-1752

Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study

Authors: Dano, Hélène, Altinay, Serdar, Arnould, Laurent, Bletard, Noella, Colpaert, Cecile, Dedeurwaerdere, Franceska, Dessauvagie, Benjamin, Duwel, Valérie, Floris, Giuseppe, Fox, Stephen, Gerosa, Clara, Jaffer, Shabnam, Kurpershoek, Eline, Lacroix-Triki, Magali, Laka, Andoni, Lambein, Kathleen, MacGrogan, Gaëtan Marie, Marchió, Caterina, Martinez, Dolores Martin, Nofech-Mozes, Sharon, Peeters, Dieter, Ravarino, Alberto, Reisenbichler, Emily, Resetkova, Erika, Sanati, Souzan, Schelfhout, Anne-Marie, Schelfhout, Vera, Shaaban, Abeer M., Sinke, Renata, Stanciu-Pop, Claudia Maria, Stobbe, Claudia, van Deurzen, Carolien H.M., Van de Vijver, Koen, Van Rompuy, Anne-Sophie, Verschuere, Stephanie, Vincent-Salomon, Anne, Wen, Hannah, Bouzin, Caroline, Galant, Christine, Van Bockstal, Mieke R.

Source: In Modern Pathology March 2020 33(3):354-366

Interobserver variability in breast carcinoma grading results in prognostic stage differences

Authors: Rabe, Kimmie, Snir, Olivia L., Bossuyt, Veerle, Harigopal, Malini, Celli, Romulo, Reisenbichler, Emily S.

Source: In Human Pathology December 2019 94:51-57

Differences in immunohistochemistry utilization by general and breast subspecialty pathologists at a large academic institution

Authors: Compton, Margaret L., Hogan, Melissa, Reisenbichler, Emily S.

Source: In Annals of Diagnostic Pathology October 2019 42:92-95

The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

Authors: Gonzalez‐Ericsson, Paula I, Stovgaard, Elisabeth S, Sua, Luz F, Reisenbichler, Emily, Kos, Zuzana, Carter, Jodi M, Michiels, Stefan, Le Quesne, John, Nielsen, Torsten O, Lænkholm, Anne‐Vibeke, Fox, Stephen B, Adam, Julien, Bartlett, John MS, Rimm, David L, Quinn, Cecily, Peeters, Dieter, Dieci, Maria V, Vincent‐Salomon, Anne, Cree, Ian, Hida, Akira I, Balko, Justin M, Haynes, Harry R, Frahm, Isabel, Acosta‐Haab, Gabriela, Balancin, Marcelo, Bellolio, Enrique, Yang, Wentao, Kirtani, Pawan, Sugie, Tomoharu, Ehinger, Anna, Castaneda, Carlos A, Kok, Marleen, McArthur, Heather, Siziopikou, Kalliopi, Badve, Sunil, Fineberg, Susan, Gown, Allen, Viale, Giuseppe, Schnitt, Stuart J, Pruneri, Giancarlo, Penault‐Llorca, Frederique, Hewitt, Stephen, Thompson, E Aubrey, Allison, Kimberly H, Symmans, William F, Bellizzi, Andrew M, Brogi, Edi, Moore, David A, Larsimont, Denis, Dillon, Deborah A, Lazar, Alexander, Lien, Huangchun, Goetz, Matthew P, Broeckx, Glenn, El Bairi, Khalid, Harbeck, Nadia, Cimino‐Mathews, Ashley, Sotiriou, Christos, Adams, Sylvia, Liu, Shi‐wei, Loibl, Sibylle, Chen, I‐Chun, Lakhani, Sunil R, Juco, Jonathan W, Denkert, Carsten, Blackley, Elizabeth F, Demaria, Sandra, Leon‐Ferre, Roberto, Gluz, Oleg, Zardavas, Dimitrios, Emancipator, Kenneth, Ely, Scott, Loi, Sherene, Salgado, Roberto, Sanders, Melinda

Source: Journal of pathology. 250(5):667-684

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100112968721.0x000001&indx=1&recIds=ETOCvdc_100112968721.0x000001

Can tumor-associated macrophages in ductal carcinoma in situ on biopsy predict invasive carcinoma on excision?

Authors: Hoskoppal, Deepthi, Reisenbichler, Emily S.

Source: In Human Pathology December 2018 82:158-162

Intraoperative sentinel lymph node evaluation: Optimizing surgical pathology practices in an era of changing clinical management

Authors: Compton, Margaret L., Sweeting, Raeshell S., Reisenbichler, Emily S.

Source: In Annals of Diagnostic Pathology April 2018 33:45-50

Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at

Authors: Podoll, Mirna B., Reisenbichler, Emily S., Roland, Lania, Bruner, Andrew, Mizuguchi, Sarah, Sanders, Mary Ann G.

Source: Archives of pathology & laboratory medicine. 142(9):1120-1126

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631238660&indx=1&recIds=ETOCRN631238660

Reporting the greatest linear extent of ductal carcinoma in situ on needle core biopsy

Authors: Reisenbichler, Emily S., Hameed, Omar

Source: In Human Pathology April 2016 50:140-145

The clinical use of a P63/cytokeratin7/18/cytokeratin5/14 antibody cocktail in diagnostic breast pathology

Authors: Reisenbichler, Emily S., Ross, John R., Hameed, Omar

Source: In Annals of Diagnostic Pathology December 2014 18(6):313-318

Association between low estrogen receptor positive breast cancer and staining performance

Authors: Caruana, Dennis, Wei, Wei, Martinez-Morilla, Sandra, Rimm, David L., Reisenbichler, Emily S.

Source: NPJ breast cancer. 6(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100161828904.0x000001&indx=1&recIds=ETOCvdc_100161828904.0x000001

Luminal cytokeratin expression profiles of breast papillomas and papillary carcinomas and the utility of a cytokeratin 5/p63/cytokeratin 8/18 antibody cocktail in their distinction

Authors: Reisenbichler, Emily S, Balmer, Nicole N, Adams, Amy L, Pfeifer, John D, Hameed, Omar

Source: In Modern Pathology February 2011 24(2):185-193